Tevogen Bio (TVGN) News Today $1.34 -0.11 (-7.59%) Closing price 01/30/2025 04:00 PM EasternExtended Trading$1.34 +0.00 (+0.37%) As of 01/30/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Tevogen Bio Holdings Inc. (TVGN): Accelerating Precision Medicine with Microsoft AI CollaborationJanuary 29 at 3:15 PM | insidermonkey.comTevogen Bio (NASDAQ:TVGN) Shares Down 8.9% - Time to Sell?Tevogen Bio (NASDAQ:TVGN) Trading Down 8.9% - Time to Sell?January 29 at 4:22 AM | marketbeat.comTevogen receives initial $2M grant, may receive $8M more at future dateJanuary 28 at 9:11 PM | markets.businessinsider.comTevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant FundingJanuary 28 at 4:04 PM | finance.yahoo.comTevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant FundingJanuary 28 at 3:49 PM | globenewswire.comTevogen Bio Stock Soars on Expanded Team-Up with MicrosoftJanuary 27, 2025 | marketwatch.comTevogen Bio CEO Congratulates Lynne Patton on Being Appointed Deputy Assistant to the President and Director of Minority OutreachJanuary 27, 2025 | globenewswire.comTevogen Bio stock surges after expanded AI partnership with MicrosoftJanuary 27, 2025 | seekingalpha.comWhat's Going On With Tevogen Bio Stock Today?January 27, 2025 | benzinga.comTevogen Bio and Microsoft expand AI collaboration to PredicTcell techJanuary 27, 2025 | finance.yahoo.comTevogen Bio Holdings, Inc. (TVGN): Advancing Immunotherapy through AI PartnershipsJanuary 25, 2025 | msn.comTevogen Bio announces AI collaboration with MicrosoftJanuary 25, 2025 | markets.businessinsider.comStocks to Watch: Richardson Electronics, Tevogen Bio HoldingsJanuary 24, 2025 | marketwatch.comTevogen stock rallies on expanded Microsoft AI collaborationJanuary 24, 2025 | msn.comTevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on AzureJanuary 24, 2025 | globenewswire.comTevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare ConferenceJanuary 23, 2025 | globenewswire.comTevogen Bio Holdings Inc. (TVGN): AI Innovations in ImmunotherapyJanuary 17, 2025 | msn.comTevogen Bio Holdings Inc. (NASDAQ:TVGN) Sees Large Decline in Short InterestTevogen Bio Holdings Inc. (NASDAQ:TVGN - Get Free Report) was the recipient of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 1,180,000 shares, a decrease of 21.3% from the November 30th total of 1,500,000 shares. Based on an average trading volume of 16,290,000 shares, the short-interest ratio is presently 0.1 days. Approximately 4.5% of the shares of the stock are short sold.December 29, 2024 | marketbeat.comTevogen Bio to Host Panels on AI in Biopharma and Healthcare Economics at 2025 JPM Healthcare ConferenceDecember 28, 2024 | nasdaq.comTevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare ConferenceDecember 26, 2024 | globenewswire.comTevogen Bio to Host Panel "AI In Biopharma: Next Frontier of Medical Innovation" During the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 23, 2024 | globenewswire.comTevogen Bio (TVGN) Advances AI-Driven Immunotherapy with New Patent FilingDecember 20, 2024 | insidermonkey.comTevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth AgendaDecember 19, 2024 | globenewswire.comTevogen Bio Holdings Inc.: Excessive Insider Ownership And Poised For A Seasonal ReboundDecember 18, 2024 | seekingalpha.comTevogen Bio to Host Panel "Pioneering the Economics of Health: Balancing Access and Outcomes" During the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 17, 2024 | tmcnet.comTevogen Bio to Host Panel “Pioneering the Economics of Health: Balancing Access and Outcomes” During the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 17, 2024 | globenewswire.comTevogen Bio Claims $10 Billion IP Potential But Hinges On MonetizationDecember 17, 2024 | seekingalpha.comTevogen Bio Holdings Inc. (NASDAQ:TVGN) Short Interest Up 93.6% in NovemberTevogen Bio Holdings Inc. (NASDAQ:TVGN - Get Free Report) was the target of a large growth in short interest in November. As of November 30th, there was short interest totalling 1,500,000 shares, a growth of 93.6% from the November 15th total of 774,700 shares. Currently, 6.7% of the shares of the stock are short sold. Based on an average trading volume of 16,110,000 shares, the short-interest ratio is currently 0.1 days.December 12, 2024 | marketbeat.comTevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 10, 2024 | globenewswire.comDr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of FameDecember 5, 2024 | globenewswire.comTevogen Bio Holdings IncNovember 27, 2024 | morningstar.comTevogen Bio (NASDAQ:TVGN) Stock Price Down 5.6% - Should You Sell?Tevogen Bio (NASDAQ:TVGN) Trading Down 5.6% - Here's What HappenedNovember 27, 2024 | marketbeat.comTevogen Bio Prepares Organizational Readiness to Support Company’s Growth StrategyNovember 26, 2024 | markets.businessinsider.comTevogen Bio Prepares Organizational Readiness to Support Company's Growth StrategyNovember 26, 2024 | globenewswire.comTevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company ValueNovember 21, 2024 | globenewswire.comTevogen reports Q3 EPS (3c) vs (3c) last yearNovember 20, 2024 | markets.businessinsider.comTevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business ModelNovember 19, 2024 | globenewswire.comUPDATE - Tevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly FinancialsNovember 14, 2024 | globenewswire.comTevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly FinancialsNovember 14, 2024 | globenewswire.comTevogen Bio Shares Are On The Rise Monday: What's Going On?November 11, 2024 | benzinga.comTevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued OperationsNovember 8, 2024 | globenewswire.comTevogen Bio advances HPV oncology treatment TVGN 920November 7, 2024 | uk.investing.comTevogen Bio partners Microsoft for HPV treatmentNovember 6, 2024 | finance.yahoo.comTevogen Bio boekt vooruitgang met HPV-oncologiebehandeling TVGN 920November 6, 2024 | nl.investing.comTevogen leverages Microsoft partnership to deliver target identification for HPVNovember 5, 2024 | markets.businessinsider.comTevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (HPV), Advancing TVGN 920November 5, 2024 | globenewswire.comTevogen Bio Announces Appointment of Anthony Tarantino as Patient Advocate to Enhance Community Engagement and Patient SupportNovember 4, 2024 | globenewswire.comTevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing CostsOctober 31, 2024 | globenewswire.comTevogen Bio Inc: Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the CompanyOctober 30, 2024 | finanznachrichten.deTevogen regains compliance with NasdaqOctober 30, 2024 | markets.businessinsider.com Get Tevogen Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address TVGN Media Mentions By Week TVGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TVGN News Sentiment▼0.390.72▲Average Medical News Sentiment TVGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TVGN Articles This Week▼173▲TVGN Articles Average Week Get Tevogen Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Adaptive Biotechnologies News Today Replimune Group News Today Poseida Therapeutics News Today Anavex Life Sciences News Today Relay Therapeutics News Today Sana Biotechnology News Today Ginkgo Bioworks News Today LENZ Therapeutics News Today Immatics News Today Opthea News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TVGN) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMan Who Called Nvidia Says: “Your Retirement Is Inside This Building.”In 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tevogen Bio Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tevogen Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
